Education
About Us
Working with TipRanks
Follow Us
Guard Therapeutics International AB (SE:GUARD)
:GUARD
RESEARCH TOOLSreports
Summary of all the Indicators
Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Guard Therapeutics International AB’s (GUARD) Moving Averages Convergence Divergence (MACD) indicator is 1.22, suggesting Guard Therapeutics International AB is a Sell.
Guard Therapeutics International AB’s (GUARD) 20-Day exponential moving average is 16.94, while Guard Therapeutics International AB’s (GUARD) share price is kr19.15, making it a Buy.
Guard Therapeutics International AB’s (GUARD) 50-Day exponential moving average is 16.17, while Guard Therapeutics International AB’s (GUARD) share price is kr19.15, making it a Buy.
Guard Therapeutics International AB (GUARD) Pivot Points
Classic
17.00
17.85
18.50
19.35
20.00
20.85
21.50
Fibonacci
17.85
18.42
18.78
19.35
19.92
20.28
20.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Guard Therapeutics International AB (GUARD) Moving Averages
MA5
18.77Buy
18.65Buy
MA10
18.02Buy
18.01Buy
MA20
16.56Buy
16.94Buy
MA50
14.78Buy
16.17Buy
MA100
17.82Buy
17.31Buy
MA200
20.35Sell
20.30Sell
Guard Therapeutics International AB’s (GUARD) 10-Day exponential moving average is 18.01, while Guard Therapeutics International AB’s (GUARD) share price is kr19.15, making it a Buy.
Guard Therapeutics International AB’s (GUARD) 100-Day exponential moving average is 17.31, while Guard Therapeutics International AB’s (GUARD) share price is kr19.15, making it a Buy.
Guard Therapeutics International AB’s (GUARD) stock price is kr19.15 and Guard Therapeutics International AB’s (GUARD) 50-day simple moving average is 14.78, creating a Buy signal.
Guard Therapeutics International AB’s (GUARD) stock price is kr19.15 and Guard Therapeutics International AB’s (GUARD) 100-day simple moving average is 17.82, creating a Buy signal.
Guard Therapeutics International AB’s (GUARD) stock price is kr19.15 and Guard Therapeutics International AB’s (GUARD) 200-day simple moving average is 20.35, creating a Sell signal.
Guard Therapeutics International AB (GUARD) Technical Indicators
RSI (14)
67.76
Neutral
STOCH (9,6)
62.43
Neutral
STOCHRSI (14)
69.42
Neutral
MACD (12,26)
1.22
Sell
ADX (14)
51.92
Sell
Williams %R
-31.40
Buy
CCI (14)
88.40
Neutral
ATR (14)
1.33
-
Ultimate Oscillator
34.26
Neutral
ROC
24.92
Buy
Guard Therapeutics International AB’s (GUARD) Relative Strength Index (RSI) is 67.76, creating a Neutral signal.
Guard Therapeutics International AB’s (GUARD) Trend Strength Indicator (ADX) is 51.92, creating a Sell signal.
Guard Therapeutics International AB’s (GUARD) Commodity Channel Index (CCI) is 88.40, creating a Neutral signal.
Guard Therapeutics International AB’s (GUARD) Price Rate of Change (ROC) is 24.92, creating a Buy signal.
FAQ
Is GUARD a Buy, Hold, or Sell?
Based on GUARD’s technical indicators, GUARD is a Buy.
What is GUARD’s RSI (14)?
GUARD’s RSI (14) is 67.76, which suggests GUARD is a Neutral.
What is GUARD’s MACD?
GUARD’s MACD is 1.22, which suggests GUARD is a Sell.
What is GUARD’s 5-day moving average?
GUARD’s 5-day moving average is 18.77, which suggests GUARD is a Buy.
What is GUARD’s 20-day moving average?
GUARD 20-day moving average is 16.56, which suggests GUARD is a Buy.
What is GUARD’s 50-day moving average?
GUARD’s 50-day moving average is 14.78, which suggests GUARD is a Buy.
What is GUARD’s 200-day moving average?
GUARD’s 200-day moving average is 20.35, which suggests GUARD is a Sell.
What is GUARD’s Williams % R (14)?
GUARD’s Williams % R (14) is -31.40, which suggests GUARD is a Buy.
What is GUARD’s CCI (14)?
GUARD’s CCI (14) is 88.40, which suggests GUARD is a Neutral.
What is the share price of Guard Therapeutics International AB?